Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-22 @ 9:27 AM
Study NCT ID:
NCT04026412
Status:
COMPLETED
Last Update Posted:
2025-07-24
First Post:
2019-07-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-18
First Submit QC Date:
None
Study First Post Date:
2019-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-17
Results First Submit QC Date:
None
Results First Post Date:
2025-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-05
Last Update Post Date:
2025-07-24
Last Update Post Date Type:
ACTUAL